•
Jun 30, 2024
•
/

Ascendis Pharma Q2 2024 Earnings Report

Total Revenue
€36.2M
Previous year: €48.1M
-24.8%
EPS
-€1.92
Previous year: -€2.19
-12.1%
Gross Profit
€22.7M
Cash and Equivalents
€259M
Free Cash Flow
-€61.7M
Total Assets
€759M

Ascendis Pharma

Ascendis Pharma